|
US3749088A
(en)
|
1971-06-23 |
1973-07-31 |
W Kohlmann |
Surgical retractor device
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
JP2823959B2
(ja)
|
1991-10-24 |
1998-11-11 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
改良された取り込みおよびその他の性質を持つ誘導化オリゴヌクレオチド
|
|
IL129507A0
(en)
|
1996-11-13 |
2000-02-29 |
Qbi Entpr Ltd |
Gene identification method
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
EP1015469B2
(en)
|
1997-09-12 |
2015-11-18 |
Exiqon A/S |
Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
|
|
US6139493A
(en)
*
|
1998-07-08 |
2000-10-31 |
Koros; Tibor B. |
Retractor with adjustable length blades and light pipe guides
|
|
BRPI0008131B8
(pt)
|
1999-02-12 |
2021-05-25 |
Daiichi Sankyo Co Ltd |
composto ou um sal deste, análogo de oligonucleotídeo, composição farmacêutica, sonda para um gene,iniciador para começar a amplificação, uso de um análogo de oligonucleotídeo ou de um sal deste farmacologicamente aceitável, agente antisentido, e, agente antígeno
|
|
ATE356824T1
(de)
|
1999-05-04 |
2007-04-15 |
Santaris Pharma As |
L-ribo-lna analoge
|
|
US6617442B1
(en)
|
1999-09-30 |
2003-09-09 |
Isis Pharmaceuticals, Inc. |
Human Rnase H1 and oligonucleotide compositions thereof
|
|
GB2375172A
(en)
|
2000-02-07 |
2002-11-06 |
Quark Biotech Inc |
Fas pathway genes
|
|
JP2005506098A
(ja)
*
|
2001-01-29 |
2005-03-03 |
デピュイ スパイン、インコーポレイテッド |
脊髄椎弓根スクリュー配置用開創器及びその方法
|
|
AU2002324700A1
(en)
|
2001-08-14 |
2003-03-03 |
Bayer Ag |
Nucleic acid and amino acid sequences involved in pain
|
|
WO2005060667A2
(en)
|
2003-12-19 |
2005-07-07 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
|
EP1470247A2
(en)
|
2001-11-05 |
2004-10-27 |
Deutsches Krebsforschungszentrum |
Novel genetic markers for leukemias
|
|
US20030157082A1
(en)
|
2002-01-31 |
2003-08-21 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480,20893, 33230,1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules
|
|
US20040101855A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of PPAR binding protein expression
|
|
US9259144B2
(en)
|
2002-07-11 |
2016-02-16 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
AU2003255337A1
(en)
|
2002-07-31 |
2004-02-23 |
Kylix B.V. |
Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
|
|
JP2006513701A
(ja)
|
2002-10-11 |
2006-04-27 |
アーラム バイオシステムズ インコーポレイテッド |
核酸ベースのシグナルトランスデューサーを含む立体構造的に敏感なプローブを有する標的検出システム
|
|
US7850608B2
(en)
|
2002-10-25 |
2010-12-14 |
K2M, Inc. |
Minimal incision maximal access MIS spine instrumentation and method
|
|
EP2284269B1
(en)
*
|
2002-11-18 |
2017-08-09 |
Roche Innovation Center Copenhagen A/S |
Antisense design
|
|
US7691057B2
(en)
|
2003-01-16 |
2010-04-06 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
US7256200B2
(en)
|
2003-02-10 |
2007-08-14 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Method and composition for potentiating an oplate analgesic
|
|
US7819801B2
(en)
|
2003-02-27 |
2010-10-26 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
US20050085436A1
(en)
|
2003-07-08 |
2005-04-21 |
Hao Li |
Method to treat conditions associated with insulin signalling dysregulation
|
|
US7481766B2
(en)
|
2003-08-14 |
2009-01-27 |
Synthes (U.S.A.) |
Multiple-blade retractor
|
|
US20050137461A1
(en)
*
|
2003-12-18 |
2005-06-23 |
Depuy Spine, Inc. |
Telescoping blade assembly and instruments for adjusting an adjustable blade
|
|
US7374927B2
(en)
*
|
2004-05-03 |
2008-05-20 |
Affymetrix, Inc. |
Methods of analysis of degraded nucleic acid samples
|
|
WO2006042241A2
(en)
|
2004-10-08 |
2006-04-20 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
JP2006223228A
(ja)
|
2005-02-18 |
2006-08-31 |
Dainippon Sumitomo Pharma Co Ltd |
自己免疫疾患治療剤のスクリーニング方法
|
|
US20060287584A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Javier Garcia-Bengochia |
Surgical retractor extensions
|
|
CN1904900A
(zh)
*
|
2005-07-28 |
2007-01-31 |
中国科学院生物物理研究所 |
人类的内源性siRNA序列及其应用和筛选方法
|
|
WO2007031091A2
(en)
|
2005-09-15 |
2007-03-22 |
Santaris Pharma A/S |
Rna antagonist compounds for the modulation of p21 ras expression
|
|
EP1962888A2
(en)
|
2005-11-18 |
2008-09-03 |
Myogen, Inc. |
Uses for camkii and hdacs in the treatment of heart conditions
|
|
DE602007009487D1
(de)
|
2006-01-27 |
2010-11-11 |
Isis Pharmaceutical Inc |
6-modifizierte bicyclische nukleinsäureanaloga
|
|
US20090156540A1
(en)
*
|
2006-03-07 |
2009-06-18 |
Mckenna Katherine |
Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same
|
|
EP2505646A1
(en)
|
2006-05-05 |
2012-10-03 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of CRP
|
|
CA2651453C
(en)
|
2006-05-11 |
2014-10-14 |
Isis Pharmaceuticals, Inc. |
5'-modified bicyclic nucleic acid analogs
|
|
US7666854B2
(en)
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
|
WO2008020435A2
(en)
|
2006-08-15 |
2008-02-21 |
Quark Pharmaceuticals, Inc |
Compositions and methods for treatment of mood disorders
|
|
ES2534430T3
(es)
|
2006-08-28 |
2015-04-22 |
The University Of Western Australia |
Método de modulación de la expresión del receptor del factor de crecimiento epidérmico (EGFR) que implica miARN
|
|
GB0617222D0
(en)
|
2006-08-31 |
2006-10-11 |
Vereniging Het Nl Kanker I |
Antibiotics
|
|
US8062217B2
(en)
*
|
2007-01-26 |
2011-11-22 |
Theken Spine, Llc |
Surgical retractor with removable blades and method of use
|
|
US8580756B2
(en)
|
2007-03-22 |
2013-11-12 |
Santaris Pharma A/S |
Short oligomer antagonist compounds for the modulation of target mRNA
|
|
DK2170917T3
(da)
|
2007-05-30 |
2012-10-08 |
Isis Pharmaceuticals Inc |
N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro
|
|
WO2008154401A2
(en)
|
2007-06-08 |
2008-12-18 |
Isis Pharmaceuticals, Inc. |
Carbocyclic bicyclic nucleic acid analogs
|
|
US20100273854A1
(en)
*
|
2007-06-15 |
2010-10-28 |
Hagar Kalinski |
Compositions and methods for inhibiting nadph oxidase expression
|
|
AU2008272918B2
(en)
|
2007-07-05 |
2012-09-13 |
Isis Pharmaceuticals, Inc. |
6-disubstituted bicyclic nucleic acid analogs
|
|
DE202007012284U1
(de)
|
2007-09-01 |
2007-10-25 |
Aesculap Ag & Co. Kg |
Chirurgischer Retraktor
|
|
WO2009067647A1
(en)
|
2007-11-21 |
2009-05-28 |
Isis Pharmaceuticals, Inc. |
Carbocyclic alpha-l-bicyclic nucleic acid analogs
|
|
US8841423B2
(en)
|
2008-04-28 |
2014-09-23 |
University Of Iowa Research Foundation |
Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II
|
|
WO2010036698A1
(en)
|
2008-09-24 |
2010-04-01 |
Isis Pharmaceuticals, Inc. |
Substituted alpha-l-bicyclic nucleosides
|
|
EP2177615A1
(en)
|
2008-10-10 |
2010-04-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
|
|
US8226554B2
(en)
|
2008-10-30 |
2012-07-24 |
Warsaw Orthopedic, Inc. |
Retractor assemblies for surgery in a patient
|
|
WO2010120969A1
(en)
|
2009-04-15 |
2010-10-21 |
Board Of Regents, The University Of Texas System |
Targeting of the mir-30 family and let-7 family as a treatment for heart disease
|
|
WO2010142805A1
(en)
*
|
2009-06-12 |
2010-12-16 |
Santaris Pharma A/S |
New potent anti apob antisense compounds
|
|
US8563528B2
(en)
*
|
2009-07-21 |
2013-10-22 |
Santaris Pharma A/S |
Antisense oligomers targeting PCSK9
|
|
EP2462153B1
(en)
|
2009-08-06 |
2015-07-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
|
US9364495B2
(en)
|
2009-10-20 |
2016-06-14 |
Roche Innovation Center Copenhagen A/S |
Oral delivery of therapeutically effective LNA oligonucleotides
|
|
US9737288B2
(en)
*
|
2010-03-11 |
2017-08-22 |
Globus Medical, Inc |
Tissue retractor and methods of use
|
|
US8846637B2
(en)
|
2010-06-08 |
2014-09-30 |
Isis Pharmaceuticals, Inc. |
Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
US20130253035A1
(en)
|
2010-08-16 |
2013-09-26 |
Duke University |
Camkk-beta as a target for treating cancer
|
|
EP2742138B1
(en)
|
2011-08-09 |
2020-06-24 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells
|
|
US10023861B2
(en)
|
2011-08-29 |
2018-07-17 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
EP2751567B1
(en)
*
|
2011-09-01 |
2019-05-08 |
University of Iowa Research Foundation |
Oligonucleotide-based probes for detection of bacterial nucleases
|
|
JP2014531425A
(ja)
|
2011-09-02 |
2014-11-27 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
肥満の代謝異常を治療するためのCaMKII、IP3R、カルシニューリン、p38、およびMK2/3阻害剤
|
|
EP2753631A1
(en)
|
2011-09-07 |
2014-07-16 |
Marina Biotech, Inc. |
Synthesis and uses of nucleic acid compounds with conformationally restricted monomers
|
|
WO2013151999A1
(en)
|
2012-04-02 |
2013-10-10 |
President And Fellows Of Harvard College |
Cancer treatment and immune system regulation through fat10 pathway inhibition
|
|
EP2850092B1
(en)
|
2012-04-09 |
2017-03-01 |
Ionis Pharmaceuticals, Inc. |
Tricyclic nucleic acid analogs
|
|
WO2013173637A1
(en)
*
|
2012-05-16 |
2013-11-21 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating gene expression
|
|
CA2889044A1
(en)
|
2012-11-15 |
2014-05-22 |
Roche Innovation Center Copenhagen A/S |
Anti apob antisense conjugate compounds
|
|
WO2014077693A1
(en)
*
|
2012-11-16 |
2014-05-22 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Means and methods for reducing an effect of aging in a mammalian cell
|
|
CN105517549B
(zh)
|
2013-03-06 |
2018-11-23 |
阿略斯泰罗斯医疗公司 |
CaMKII抑制剂和其用途
|
|
US20140329755A1
(en)
|
2013-05-01 |
2014-11-06 |
Gilead Sciences, Inc. |
Combination therapy for the treatment of arrhythmias or heart failure
|
|
PL2992098T3
(pl)
|
2013-05-01 |
2019-09-30 |
Ionis Pharmaceuticals, Inc. |
Kompozycje i sposoby modulowania ekspresji hbv i ttr
|
|
MX367083B
(es)
*
|
2013-06-27 |
2019-08-05 |
Roche Innovation Ct Copenhagen As |
Oligomeros antisentido y conjugados con diana en la proteina-convertasa subtilisina/kexina tipo 9(pcsk9).
|
|
CA2960101C
(en)
|
2014-09-05 |
2024-05-21 |
Allosteros Therapeutics, Inc. |
Substituted carboline derivative and compositions thereof useful as camkii inhibitors
|
|
WO2016126747A1
(en)
|
2015-02-02 |
2016-08-11 |
Meiragtx Uk Limited |
Regulation of gene expression by aptamer-mediated modulation of alternative splicing
|
|
EP3286318A2
(en)
|
2015-04-22 |
2018-02-28 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
US10494632B2
(en)
*
|
2015-07-10 |
2019-12-03 |
Alnylam Pharmaceuticals, Inc. |
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
|
|
EP3353305A4
(en)
|
2015-09-25 |
2019-09-18 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
EP3353306A4
(en)
|
2015-09-25 |
2019-06-05 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
WO2017106283A1
(en)
*
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of liver diseases
|
|
EP3481857B1
(en)
*
|
2016-07-06 |
2026-02-11 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of pain related disorders
|
|
EP3494229B1
(en)
|
2016-08-03 |
2023-10-25 |
Meiragtx UK II Limited |
High throughput cell-based screening for aptamers
|
|
WO2019049148A1
(en)
|
2017-09-10 |
2019-03-14 |
Carmel Haifa University Economic Corporation Ltd. |
METHOD OF TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER
|
|
EP3740576A4
(en)
|
2018-01-18 |
2021-10-20 |
Advanced Regen Medical Technologies, LLC |
THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
|
|
WO2019165067A1
(en)
|
2018-02-21 |
2019-08-29 |
Bristol-Myers Squibb Company |
Camk2d antisense oligonucleotides and uses thereof
|
|
CA3098623A1
(en)
|
2018-05-07 |
2019-11-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|